Literature DB >> 19135091

Effective siRNA targeting of the 3' untranslated region of the West Nile virus genome.

Karen G Anthony1, Fengwei Bai, Manoj N Krishnan, Erol Fikrig, Raymond A Koski.   

Abstract

West Nile virus (WNV) is an emerging human pathogen for which specific antiviral therapy has not been developed. The therapeutic potential of RNA interference (RNAi) as a sequence-specific inhibitor of WNV has been well demonstrated. Although multiple siRNA targets have been identified within the genomic coding region, targets within the untranslated regions (UTR), which encode cis-acting regulatory elements, remain relatively unknown. In WNV and other flaviviruses, UTRs are located at the genomic termini. These regions form complex secondary structures, which pose difficulty when designing effective siRNA targets. In this study, we report the identification of siRNA targets in the WNV 3' UTR. These targets were selected by siRNA predictor algorithms, and synthesized as short hairpin RNA sequences from a plasmid-based expression system. Vero cells stably expressing these sequences had greatly diminished ability to support WNV replication but not the related dengue virus, demonstrating that the siRNAs were effective and suppressed WNV viral replication in a sequence-specific manner. The siRNAs developed in this study could function as potential antiviral therapeutics and as genetic tools to investigate the role of 3' UTR in WNV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19135091     DOI: 10.1016/j.antiviral.2008.12.007

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  8 in total

1.  Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence.

Authors:  David A Stein; Stuart T Perry; Michael D Buck; Christopher S Oehmen; Matthew A Fischer; Elizabeth Poore; Jessica L Smith; Alissa M Lancaster; Alec J Hirsch; Mark K Slifka; Jay A Nelson; Sujan Shresta; Klaus Früh
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

Review 2.  Progress on the development of therapeutics against West Nile virus.

Authors:  Michael S Diamond
Journal:  Antiviral Res       Date:  2009-06-06       Impact factor: 5.970

3.  P247 and p523: two in vivo-expressed megalocytivirus proteins that induce protective immunity and are essential to viral infection.

Authors:  Jian Zhang; Bao Cun Zhang; Li Sun
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

Review 4.  Antiviral RNAi: translating science towards therapeutic success.

Authors:  Priya S Shah; David V Schaffer
Journal:  Pharm Res       Date:  2011-08-09       Impact factor: 4.200

Review 5.  Functional Information Stored in the Conserved Structural RNA Domains of Flavivirus Genomes.

Authors:  Alba Fernández-Sanlés; Pablo Ríos-Marco; Cristina Romero-López; Alfredo Berzal-Herranz
Journal:  Front Microbiol       Date:  2017-04-03       Impact factor: 5.640

Review 6.  Arthropod-borne flaviviruses and RNA interference: seeking new approaches for antiviral therapy.

Authors:  Mayra Diosa-Toro; Silvio Urcuqui-Inchima; Jolanda M Smit
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

Review 7.  A review on current status of antiviral siRNA.

Authors:  Abid Qureshi; Vaqar Gani Tantray; Altaf Rehman Kirmani; Abdul Ghani Ahangar
Journal:  Rev Med Virol       Date:  2018-04-15       Impact factor: 6.989

8.  SiRNA inhibits replication of Langat virus, a member of the tick-borne encephalitis virus complex in organotypic rat brain slices.

Authors:  Carola Maffioli; Denis Grandgirard; Stephen L Leib; Olivier Engler
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.